StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Arcadia Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -234.5%. For fiscal 2025 it was -48.1%, against -139.5% the year before. The highest annual figure on record is -48.1% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-48.1%+91.4
FY2024Dec 31, 2024-139.5%+174.4
FY2023Dec 31, 2023-313.9%−106.6
FY2022Dec 31, 2022-207.3%+8.9
FY2021Dec 31, 2021-216.2%−158.3
FY2020Dec 31, 2020-57.9%+2406.1
FY2019Dec 31, 2019-2464.1%−1543.3
FY2018Dec 31, 2018-920.8%−530.6
FY2017Dec 31, 2017-390.1%+225.4
FY2016Dec 31, 2016-615.6%−283.9
FY2015Dec 31, 2015-331.7%−69.0
FY2014Dec 31, 2014-262.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-434.2%−127.8
Q1 FY2026Mar 31, 2026-398.6%−615.2
Q4 FY2025Dec 31, 2025-148.3%+185.9
Q3 FY2025Sep 30, 202565.7%+170.6
Q2 FY2025Jun 30, 2025-306.4%−387.6
Q1 FY2025Mar 31, 2025216.6%+462.1
Q4 FY2024Dec 31, 2024-334.2%+33.0
Q3 FY2024Sep 30, 2024-104.9%+92.9
Q2 FY2024Jun 30, 202481.2%+17.8
Q1 FY2024Mar 31, 2024-245.5%+516.2
Q4 FY2023Dec 31, 2023-367.2%+203.2
Q3 FY2023Sep 30, 2023-197.8%−15.2
Q2 FY2023Jun 30, 202363.5%+161.4
Q1 FY2023Mar 31, 2023-761.7%−622.3
Q4 FY2022Dec 31, 2022-570.4%−142.9
Q3 FY2022Sep 30, 2022-182.6%−91.1
Q2 FY2022Jun 30, 2022-97.9%+276.5
Q1 FY2022Mar 31, 2022-139.4%−387.9
Q4 FY2021Dec 31, 2021-427.5%−552.3
Q3 FY2021Sep 30, 2021-91.5%+1943.8
Q2 FY2021Jun 30, 2021-374.4%+3073.6
Q1 FY2021Mar 31, 2021248.6%−568.6
Q4 FY2020Dec 31, 2020124.8%+1625.5
Q3 FY2020Sep 30, 2020-2035.4%+1583.8
Q2 FY2020Jun 30, 2020-3448.0%−5535.2
Q1 FY2020Mar 31, 2020817.2%+8799.4
Q4 FY2019Dec 31, 2019-1500.7%−1355.2
Q3 FY2019Sep 30, 2019-3619.1%−4821.8
Q2 FY2019Jun 30, 20192087.2%+3616.8
Q1 FY2019Mar 31, 2019-7982.3%−3022.0
Q4 FY2018Dec 31, 2018-145.5%+61.8
Q3 FY2018Sep 30, 20181202.7%+1971.0
Q2 FY2018Jun 30, 2018-1529.6%−1125.3
Q1 FY2018Mar 31, 2018-4960.3%−4546.1
Q4 FY2017Dec 31, 2017-207.3%+849.8
Q3 FY2017Sep 30, 2017-768.3%−379.9
Q2 FY2017Jun 30, 2017-404.2%–
Q1 FY2017Mar 31, 2017-414.1%–
Q4 FY2016Dec 31, 2016-1057.0%–
Q3 FY2016Sep 30, 2016-388.4%–

More Arcadia Biosciences figures

See a number that looks wrong?